Plato Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.02M Sell
46,424
-664
-1% -$63.6K 0.27% 88
2025
Q4
$4.55M Buy
47,088
+4,503
+11% +$437K 0.3% 75
2025
Q3
$4.02M Buy
42,585
+2,305
+6% +$212K 0.27% 88
2025
Q2
$3.5M Buy
40,280
+833
+2% +$70.6K 0.26% 89
2025
Q1
$3.58M Buy
39,447
+291
+0.7% +$26K 0.3% 85
2024
Q4
$3.14M Buy
39,156
+1,085
+3% +$93.9K 0.23% 97
2024
Q3
$3.42M Buy
+38,071
New +$3.2M 0.28% 86

Other funds holding MDT

Plato Investment Management's MDT Position: Q1 2026 in Review

Plato Investment Management reduced its Medtronic (MDT) stake by 1.4% in Q1 2026, selling an estimated $63.6K and leaving 46,424 shares worth $4.02M. The position accounts for 0.27% of the portfolio, ranked #88.

Plato Investment Management first reported a position in MDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.55M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Plato Investment Management held 46,424 shares of Medtronic worth $4.02M as of Q1 2026.
  • Plato Investment Management sold 664 Medtronic shares in Q1 2026, an estimated $63.6K.
  • Medtronic made up 0.27% of Plato Investment Management's portfolio in Q1 2026, its #88 holding.
  • Plato Investment Management first reported a position in Medtronic in Q3 2024 and has held it in 7 quarters since.
  • Plato Investment Management's Medtronic position peaked at $4.55M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.